Produced by: Pawan Kumar Nahar

Aptech

IPO representative
image
image

Indegene IPO: All details you need know including price band, key dates & latest GMP

IPO Stock

Indegene IPO: dates and  price band

The initial public offering (IPO) on Indegene Ltd opens today on May 6 and can be subscribed till Wednesday, May 8. The company is offering its shares in the range of Rs 430-452 apiece, with a lot size of 33 equity shares and its multiples thereafter

ipo 5

Issue Size

Indegene is looking to raise a total of Rs 1,841.76 crore via IPO including a fresh share sale of Rs 760 crore and offer for sale (OFS) of up to 2,39,32,732 equity shares. The company raised Rs 548.78 crore from anchor investors.

cropped stocks 1

Category Reservation

Indegene has reserved shares worth Rs 12.5 crore for its eligible employees, who will get a discount of Rs 30 per share. Of the net offer, 50% shares are reserved for the qualified institutional bidders (QIBs), 15% per for non-institutional investors (NIIs) and 35% for the retail investors.

Grey Market Premium

On the first day of the bidding, shares of Indegene were commanding a grey market premium (GMP) of Rs 260-265 apiece, suggesting a listing gain of 57-58% to the investors on the upper end of the price band.

BSE BUILDING SK 6 2 06 03

Dates of Allotment  and listing

Indegene is likely to finalise the basis of allotment of its shares on Thursday, May 9. The company will make its Dalal Street debut on Monday, May 13 on both BSE and NSE.

IPO

Objectives of IPO

The net proceeds for the issue shall be utilized towards repayment/prepayment of debt; funding the capital expenditure requirements of the company; and general corporate purposes and inorganic growth. Proceeds from OFS shall go to selling shareholders.

stocks1

Managers and Regsistrars

Kotak Mahindra Capital, Citigroup Global Markets India, JP Morgan India and Nomura Financial Advisory and Securities (India) are the book running lead managers of the Indegene IPO, while Link Intime India is the registrar for the issue.